Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
International Stem Cell Corp. (ISCO) had Consolidated Net Income/Loss of $-0.07M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$2.67M |
|
$-0.07M |
|
$1.22M |
|
$1.46M |
|
$2.71M |
|
$-0.04M |
|
$-0.04M |
|
$-0.07M |
|
$-0.07M |
|
$-0.07M |
|
$-0.07M |
|
|
Consolidated Net Income/Loss |
$-0.07M |
$-0.07M |
|
$-0.04M |
|
$-0.01M |
|
8.00M |
|
8.00M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$3.92M |
|
$0.16M |
|
$1.14M |
|
$5.06M |
|
$4.98M |
|
-- |
|
$4.30M |
|
$9.28M |
|
$-4.23M |
|
$-4.74M |
|
$-4.23M |
|
8.00M |
|
| Cash Flow Statement Financials | |
$0.29M |
|
$-0.04M |
|
$-0.15M |
|
$0.99M |
|
$1.09M |
|
$0.10M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
54.50% |
|
-1.31% |
|
-1.31% |
|
-- |
|
-2.65% |
|
-2.65% |
|
$0.26M |
|
-- |
|
-- |
|
-- |
|
0.53 |
|
0.72 |
|
2.79 |
|
32.27 |
|
1.68% |
|
1.50% |
|
-1.40% |
|
1.68% |
|
$-0.53 |
|
$0.03 |
|
$0.04 |
|